                               SEQUENCE LISTING

<110> AVON PRODUCTS, INC.
 
<120> PEPTIDES AND THEIR USE IN THE TREATMENT OF HAIR

<130> HC29U-WO

<140>
<141>

<150> 62/257,366
<151> 2015-11-19

<160> 8    

<170> PatentIn version 3.5

<210> 1
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Tyr Asn Thr 
1           


<210> 2
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Pro Val Gly 
1           


<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Amino valeric acid 

<400> 3
Lys Xaa Tyr Asn Thr Lys 
1               5       


<210> 4
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Amino valeric acid 

<400> 4
Lys Xaa Pro Val Gly Lys 
1               5       


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Tyr Asn Thr Lys 
1               


<210> 6
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Pro Val Gly Lys 
1               


<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ava

<220>
<221> MOD_RES
<222> (6)..(9)
<223> Any naturally occurring, non-naturally occurring 
      or non-proteinogenic amino acid residue 

<220>
<221> MISC_FEATURE
<222> (6)..(9)
<223> This region may encompass 1 to 4 amino acids wherein some
      positions may be absent

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 7
Lys Xaa Tyr Asn Thr Xaa Xaa Xaa Xaa 
1               5                   


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ava

<220>
<221> MOD_RES
<222> (6)..(9)
<223> Any naturally occurring, non-naturally occurring 
      or non-proteinogenic amino acid residue 

<220>
<221> MISC_FEATURE
<222> (6)..(9)
<223> This region may encompass 1 to 4 amino acids wherein some
      positions may be absent

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 8
Lys Xaa Pro Val Gly Xaa Xaa Xaa Xaa 
1               5                   



